drugset / Trial / NCT03546205

A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function

NCT03546205

Phase 1 Completed 40 enrolled Janssen Research & Development, LLC
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of study is to evaluate the pharmacokinetics of a single, subcutaneous dose of JNJ-64565111 in adult participants with varying degrees of renal function including participants with end stage renal disease, requiring hemodialysis, compared with participants with normal renal function.

Timeline

Start
2018-06-06
Primary completion
2018-12-17
Completion
2018-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64565111 Unknown Subcutaneous